China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Illumina is part of the Health Care sector, which has an average P/E ratio of 26.07 and an average P/B of 3.53 The company ...

and molecular techniques (DNA methylation quantification at candidate loci by pyrosequencing or at whole-genome level by bisulfite sequencing, measurements of expression of epigenome regulators) to ...

The provision will enable whole genome sequencing for neonatal and paediatric patients in intensive care units within 48 ...

Upper tract urothelial carcinoma (UTUC) is an aggressive disease that is challenging to biopsy and diagnose, frequently yielding nondiagnostic cytology and tissue specimens. Therefore, UTUC is often ...

GAITHERSBURG, Md. - GeneDx (NASDAQ:WGS), a genomic insights company with a market capitalization of $1.95 billion, announced the introduction of its ultraRapid Whole Genome Sequencing service, which ...

Whole genome sequencing can be an exceptionally valuable tool in cancer diagnostics. The application of this technique can ...

Microarray analysis identifies more chromosome abnormalities than traditional karyotyping in prenatal testing ... but when combined with certain sequencing strategies, detection of gene ...

Generating data with the method is more than 10 times less expensive than comparable high-dimensional approaches such as high-throughput single-cell RNA sequencing and can be adapted to study a ...